3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
4
Neoplasms
4
Prostatic Neoplasms
3
Glioma
3
Glioblastoma
3
Uterine Cervical Dysplasia
2
Sarcoma
2
Breast Neoplasms
2
Atypical Squamous Cells of the Cervix
2
Astrocytoma
2
Xeroderma Pigmentosum
1
Triple Negative Breast Neoplasms
1
Trichothiodystrophy Syndromes
1
Squamous Intraepithelial Lesions
1
Spinal Cord Neoplasms
1
Sexuality
1
Pilonidal Sinus
1
Peritoneal Neoplasms
1
Pelvic Organ Prolapse
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibroma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Meningioma
1
Melanoma
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leiomyoma
1
Interventions
pembrolizumab
137
Cisplatin
75
Cetuximab
51
Carboplatin
49
Paclitaxel
39
Nivolumab
38
Radiotherapy
37
Docetaxel
34
Radiotherapy, Intensity-Modulated
30
Magnetic Resonance Spectroscopy
25
Specimen Handling
20
Fluorouracil
20
Platinum
14
1,2-diaminocyclohexaneplatinum II citrate
13
Taxes
12
cemiplimab
11
Radiation
11
Ipilimumab
11
atezolizumab
10
Surgical Procedures, Operative
10
Drug Therapy
10
Biopsy
9
durvalumab
8
Radiosurgery
8
130-nm albumin-bound paclitaxel
8
tislelizumab
7
Standard of Care
7
Chemoradiotherapy
7
Albumin-Bound Paclitaxel
7
Immune Checkpoint Inhibitors
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Restraint, Physical
×
1 year
×
Clear all
No trials found.